Table 1 Clinical and laboratory data for AIS subjects divided according to their sd-LDL-c levels and hypolipemic drugs using.
sd-LDL-C | Tertiles1, n = 211 ≤ 0.64 mmol/L | Tertiles 2,n = 215 0.65-1.07 mmol/L | Tertiles 3,n = 206 ≥1.07 mmol/L | p value | Non-hypolipemic drugs users, n = 632 | Hypolipemic drugs users, n = 122 | All patients, n = 754 | p value |
---|---|---|---|---|---|---|---|---|
Age(years) | 69.1 ± 13.6 | 66.2 ± 12.0 | 61.7 ± 13.0 | <0.001 | 64.3 ± 13.2 | 70.2 ± 10.6 | 65.3 ± 13.1 | 0.001 |
BMI(kg/m2) | 22.81 ± 2.50 | 23.22 ± 2.61 | 23.44 ± 2.79 | 0.320 | 23.17 ± 2.49 | 23.38 ± 2.56 | 23.27 ± 2.52 | 0.335 |
Smoking,n(%) | 66 (31.3%) | 71 (33.0%) | 78 (7.8%) | 0.340 | 237 (37.5%) | 30 (24.3%) | 267 (35.4%) | 0.022 |
Drinking, n(%) | 40 (19.0%) | 43 (20.0%) | 53 (25.7%) | 0.194 | 152 (24.1%) | 18 (14.3%) | 170 (22.6%) | 0.045 |
HT,n(%) | 136 (64.4%) | 155 (72.1%) | 135 (65.5%) | 0.191 | 413 (65.4%) | 105 (85.7%) | 518 (68.6%) | <0.001 |
DM, n(%) | 56 (26.5%) | 75 (34.9%) | 76 (36.9%) | 0.057 | 192 (30.4%) | 37 (30.0%) | 229 (30.3%) | 0.538 |
CHD, n(%) | 14 (6.6%) | 20 (9.3%) | 22 (10.7%) | 0.335 | 44 (7.0%) | 40 (32.9%) | 84 (11.1%) | <0.001 |
Hyperlipidemia,n(%) | 55 (26.1%) | 70 (32.6%) | 106 (51.5%) | <0.001 | 154 (24.4%) | 99 (81.4%) | 253 (33.5%) | <0.001 |
AF, n(%) | 20 (9.4%) | 26 (12.1%) | 30 (14.6%) | 0.280 | 72 (11.4%) | 19 (15.7%) | 91 (12.0%) | 0.201 |
SBP,mmHg | 149.8 ± 26.3 | 149.7 ± 24.7 | 152.9 ± 26.5 | 0.597 | 149.2 ± 26.1 | 155.1 ± 27.7 | 150.3 ± 26.1 | 0.088 |
DBP, mmHg | 81.8 ± 13.6 | 83.2 ± 15.1 | 88.8 ± 15.9 | 0.05 | 84.7 ± 15.5 | 85.5 ± 15.1 | 85.0 ± 15.3 | 0.680 |
Cr (umol/L) | 77.3 ± 28.4 | 76.8 ± 29.1 | 78.2 ± 28.6 | 0.881 | 76.1 ± 29.8 | 80.5 ± 30.7 | 76.4 ± 29.1 | 0.269 |
UA (umol/L) | 345.6 ± 105.2 | 368.9 ± 120.5 | 392.7 ± 120.1 | 0.005 | 369.6 ± 121.1 | 370.8 ± 112.8 | 369.7 ± 117.5 | 0.938 |
TC (mmol/L) | 3.96 ± 0.95 | 4.51 ± 0.89 | 5.11 ± 0.96 | <0.001 | 5.09 ± 1.16 | 4.39 ± 0.99 | 4.62 ± 1.05 | <0.001 |
TG (mmol/L) | 1.28 ± 0.69 | 1.63 ± 1.40 | 2.25 ± 1.49 | <0.001 | 2.11 ± 1.88 | 1.60 ± 1.13 | 1.69 ± 1.30 | 0.002 |
HDL-C (mmol/L) | 1.20 ± 0.65 | 1.07 ± 0.33 | 1.14 ± 0.39 | 0.105 | 1.13 ± 0.64 | 1.14 ± 0.40 | 1.13 ± 0.59 | 0.883 |
LDL-C (mmol/L) | 2.21 ± 0.93 | 2.61 ± 0.71 | 2.96 ± 0.85 | <0.001 | 2.87 ± 1.00 | 2.52 ± 0.82 | 2.77 ± 0.85 | 0.002 |
ApoA1 (g/L) | 1.30 ± 0.22 | 1.33 ± 0.25 | 1.29 ± 0.23 | 0.787 | 1.31 ± 0.21 | 1.33 ± 0.26 | 1.31 ± 0.22 | 0.612 |
ApoB (g/L) | 0.70 ± 0.17 | 0.91 ± 0.24 | 1.06 ± 0.22 | <0.001 | 0.90 ± 0.25 | 0.99 ± 0.25 | 0.91 ± 0.25 | 0.008 |
TC/HDL | 3.66 ± 0.95 | 4.27 ± 1.35 | 5.12 ± 1.44 | <0.001 | 4.78 ± 1.69 | 4.28 ± 1.33 | 4.33 ± 1.38 | 0.006 |
TG/HDL | 1.22 ± 0.81 | 1.65 ± 1.60 | 2.29 ± 1.70 | <0.001 | 2.15 ± 1.28 | 1.63 ± 1.32 | 1.72 ± 1.51 | 0.009 |
ApoB/ ApoA1 | 0.54 ± 0.13 | 0.70 ± 0.20 | 0.85 ± 0.27 | <0.001 | 0.70 ± 0.22 | 0.78 ± 0.35 | 0.72 ± 0.25 | 0.023 |
HbA1c (%) | 6.70 ± 1.60 | 6.76 ± 1.63 | 7.42 ± 1.59 | 0.110 | 7.06 ± 1.48 | 7.00 ± 1.84 | 7.04 ± 1.63 | 0.919 |
D-dimer (mg/L) | 1.22 ± 2.01 | 1.35 ± 2.38 | 1.27 ± 2.56 | 0.953 | 1.25 ± 2.40 | 1.60 ± 2.48 | 1.25 ± 2.33 | 0.276 |
Hcys (umol/L) | 20.22 ± 12.39 | 21.87 ± 16.31 | 16.52 ± 8.94 | 0.05 | 19.17 ± 12.64 | 18.54 ± 10.21 | 19.1 ± 12.4 | 0.723 |
IAC score | 3.36 ± 3.23 | 3.57 ± 3.41 | 4.45 ± 3.78 | 0.01 | 3.65 ± 3.46 | 4.82 ± 3.77 | 3.83 ± 3.50 | 0.01 |
Death,n (%) | 20 (9.5%) | 23 (10.7%) | 29 (14.1%) | 0.310 | 72 (11.6%) | 13 (10.7%) | 85 (11.3%) | 0.324 |
NIHSS score | 5.11 ± 5.05 | 6.67 ± 6.10 | 7.89 ± 6.68 | <0.001 | 6.31 ± 6.12 | 8.25 ± 7.39 | 6.55 ± 6.34 | 0.019 |
mRS score | 2.13 ± 1.64 | 2.30 ± 1.79 | 2.50 ± 1.81 | 0.225 | 2.30 ± 1.82 | 2.66 ± 1.83 | 2.34 ± 1.82 | 0.134 |
Severe IAC, n (%) | 22 (10.4%) | 30 (13.9%) | 50 (24.3%) | <0.001 | 85 (13.4%) | 32 (26.2%) | 117 (15.5%) | 0.001 |